1.
Clinical epidemiology of heart failure
by Mosterd, Arend
Heart (British Cardiac Society), 2007-09, Vol.93 (9), p.1137-1146
2.
Reducing myocardial infarct size: challenges and future opportunities
by Bulluck, Heerajnarain
Heart, 2016-03, Vol.102 (5), p.341-348
3.
Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial
by Bolli, Roberto, Prof
The Lancet (British edition), 2011, Vol.378 (9806), p.1847-1857
4.
Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinr...
by Abbate, Antonio, MD, PhD
The American journal of cardiology, 2013, Vol.111 (10), p.1394-1400
5.
Rhythm control in atrial fibrillation
by Piccini, Jonathan P, Dr
The Lancet (British edition), 2016, Vol.388 (10046), p.829-840
6.
Effects of Dietary Approaches to Stop Hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases—Incidence: A systematic review and meta-analysis on observational...
by Salehi-Abargouei, Amin, M.Sc. Nutr., Ph.D. Cand
Nutrition (Burbank, Los Angeles County, Calif.), 2013, Vol.29 (4), p.611-618
7.
From epidemiological transition to modern cardiovascular epidemiology: hypertension in the 21st century
by Blacher, Jacques, Prof
The Lancet (British edition), 2016, Vol.388 (10043), p.530-532
8.
Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (t...
by Fox, K M
The Lancet (British edition), 2003-09-06, Vol.362 (9386), p.782-788
9.
Exercise Training and Cardiac Rehabilitation in Primary and Secondary Prevention of Coronary Heart Disease
by Lavie, Carl J
Mayo Clinic proceedings, 2009, Vol.84 (4), p.373-383
10.
Chlorthalidone Reduces Cardiovascular Events Compared With Hydrochlorothiazide: A Retrospective Cohort Analysis
by Dorsch, Michael P
Hypertension (Dallas, Tex. 1979), 2011-04, Vol.57 (4), p.689-694
11.
Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
by Steinberg, Benjamin A., MD
The American heart journal, 2014, Vol.167 (5), p.735-742.e2
12.
Recent advances in the epidemiology, pathogenesis and prognosis of acute heart failure and cardiomyopathy in Africa
by Sliwa, Karen
Heart (British Cardiac Society), 2013-09, Vol.99 (18), p.1317-1322
13.
Telephone Counseling for Patients with Chronic Heart Failure: Results of an Evaluation Study
by Böhme, Sylvia
International journal of behavioral medicine, 2011-07-06, Vol.19 (3), p.288-297
14.
Zinc and cardiovascular disease
by Little, Peter J., Ph.D
Nutrition (Burbank, Los Angeles County, Calif.), 2010, Vol.26 (11), p.1050-1057
15.
EMPA-REG – the “diuretic hypothesis”
by McMurray, John
Journal of diabetes and its complications, 2016, Vol.30 (1), p.3-4
16.
SGLT-2 inhibitors in heart failure: a new therapeutic avenue
by Vaduganathan, Muthiah
Nature medicine, 2019-11, Vol.25 (11), p.1653-1654
17.
Adherence With Antihypertensive Drug Therapy and the Risk of Heart Failure in Clinical Practice
by Corrao, Giovanni
Hypertension (Dallas, Tex. 1979), 2015-10, Vol.66 (4), p.742-749
18.
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
by Turnbull, Fiona
The Lancet (British edition), 2003-11-08, Vol.362 (9395), p.1527-1535
19.
The pathophysiology of hypertensive acute heart failure
by Viau, David M
Heart (British Cardiac Society), 2015-12, Vol.101 (23), p.1861-1867
20.
Metformin treatment is associated with a low risk of mortality in diabetic patients with heart failure: a retrospective nationwide cohort study
by Andersson, C
Diabetologia, 2010-09-14, Vol.53 (12), p.2546-2553
